The $1.75 billion deal for Alios BioPharma marks the first acquisition in some time for Johnson & Johnson. Alios is working on treatments for viral diseases.

Topics:  alios biopharma   johnson   
BING NEWS:
  • Michael Johnson secures funds for new track league
    Olympic champion Michael Johnson has secured more than $30M from investors and strategic partners for a track league he plans to launch next year.
    04/23/2024 - 5:33 am | View Link
  • Sarasota biotech company noncompliant with NYSE listing standards
    Oragenics was notified by the New York Stock Exchange American that its stockholders' equity total was below a required threshold.
    04/22/2024 - 7:15 am | View Link
  • Johnson & Johnson: Buy This Bargain Before It's Gone
    Johnson & Johnson exceeds expectations with strong financial results and impressive sales growth. Read more to see why I am bullish on JNJ stock.
    04/18/2024 - 12:28 am | View Link
  • Does Johnson & Johnson's Latest Acquisition Make It a No-Brainer Buy?
    What does this mean for the company, and does this move make Johnson & Johnson an attractive option for growth investors? The acquisition will strengthen its medtech business. Joh ...
    04/9/2024 - 9:57 pm | View Link
  • Johnson & Johnson to Buy Shockwave Medical for $13.1 Billion. It’s a Cardio Health Play.
    Johnson & Johnson agreed to acquire medical-devices maker Shockwave Medical for a total enterprise value of about $13.1 billion. Johnson & Johnson will pay $335 a share in cash for Shockwave, J&J said ...
    04/5/2024 - 2:59 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News